Dr Diu T.T. Nguyen
Diu received her undergraduate degree in Biology from Hanoi University of Science, Vietnam. She obtained her MSc in Biomolecular Sciences from Vrije Universiteit Amsterdam and the Whitehead Institute for Biomedical Research, MIT, under support from Huygens Scholarship. She was awarded an EC Marie Curie fellowship to complete her PhD (DPhil) from the University of Oxford, UK. Her PhD work focused on the role of chromatin remodeling factor ATRX in congenital genetic disorders and cancers. She uncovered the genomic regions ATRX interacts with and how ATRX loss leads to genome instability. Diu then moved to the Memorial Sloan-Kettering Cancer Center in New York, USA for her postdoctoral training in Dr. Michael Kharas’ laboratory, investigating the role of post-transcriptional regulation in normal and malignant cancer stem cells. She pioneered the use of RNA-editing based approaches to identify RNA targets of RNA-Binding Proteins (RBPs) in mammalian stem cells, as well as discovered the oncogenic role of a number of RBPs in blood cancer. Diu was awarded a Scholar Fellowship from the American Society of Hematology (ASH) for her transition to independence. In August 2020, Diu received a Career Development Fellowship from the Cancer Research UK to start her own group at the Barts Cancer Institute.